View More
Expert faculty present key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.
Kenneth Cusi, MD, FACP, FACE
Brent A. Neuschwander-Tetri, MD
Released: December 6, 2018
Expert hepatologist presents key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.
Brent A. Neuschwander-Tetri, MD
Released: December 13, 2018
Expert endocrinologist presents key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.
Kenneth Cusi, MD, FACP, FACE
Expert faculty present key data on current and emerging NASH treatment options for your patients
Juan Pablo Frias, MD, FACE
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: January 18, 2019
Expert hepatologist presents key data on current and emerging NASH treatment options for your patients
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: January 18, 2019
Expert endocrinologist presents key data on current and emerging NASH treatment options for your patients
Juan Pablo Frias, MD, FACE
Released: January 22, 2019
Expert faculty present key data on current and emerging NASH treatment options for your patients.
Rita Basu, MD
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Released: February 11, 2019
Expert endocrinologist presents current and emerging approaches to identifying NASH and significant fibrosis.
Rita Basu, MD
Released: February 13, 2019
Expert hepatologist presents current and emerging approaches to identifying NASH and significant fibrosis.
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Released: February 15, 2019
Expert faculty present key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH
Philip N. Newsome, PhD, FRCPE
Raymond E. Soccio, MD, PhD
Released: March 5, 2019
Expert hepatologist presents key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH
Philip N. Newsome, PhD, FRCPE
Released: March 6, 2019
Expert endocrinologist presents key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH
Raymond E. Soccio, MD, PhD
Released: March 7, 2019
Expert faculty explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 26, 2019
Expert hepatologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 29, 2019
Expert endocrinologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.